Rapt Therapeutics, Inc. (RAPT)
57.72
-0.02
(-0.03%)
USD |
NASDAQ |
Feb 11, 16:00
57.86
+0.14
(+0.24%)
After-Hours: 07:26
Rapt Therapeutics Total Liabilities (Quarterly) : 13.76M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Penumbra, Inc. | 385.67M |
| Boston Scientific Corp. | -- |
| Johnson & Johnson | -- |
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.74M |
| Shareholders Equity (Quarterly) | 151.98M |
| Debt to Equity Ratio | 0.0171 |
| Current Ratio | 12.04 |
| Net Debt Paydown Yield | 0.15% |